A Core Technology Pathway, Building a Global Technology Moat

CellUranics has pioneered a proprietary technology platform featuring a fully independent, non-grain-based production chain: Glucose → GA → FDCA. This continuous, full-chain roadmap breaks the technological monopoly long held by Europe and the U.S. at its source, enabling independent control alongside low-cost, large-scale production of bio-based materials.

Non-grain Biomass

Glucose

GA

FDCA

Bio-based Polymer Materials

All-scenario Applications

Technical Highlights

Non-Grain Carbon Source Pathway: Safeguarding National Food Security

Flexible Raw Material Sourcing: Utilizes glucose as a primary feedstock, fully compatible with diverse non-grain carbon sources.

Zero Competition with Food Supply: Eliminates competition with grain for arable land, ensuring an abundant, low-cost, and readily available supply chain.

Strategic Alignment: Deeply aligned with national "Dual Carbon" goals and food security strategies.

Fully Proprietary IP Across the Value Chain: Shattering Technological Monopolies

Pioneering Non-Food Glucose Route: Innovates a unique technology pathway based on non-food glucose.

End-to-End Proprietary IP: Holds complete proprietary intellectual property rights across the entire production chain.

Technological Sovereignty: Breaks the long-standing technological monopolies held by Europe and the U.S., achieving full independence and control.

Continuous Production Process: Paving the Way for Industrialization

Scalability Breakthrough: Overcomes traditional scaling challenges through advanced continuous production technology.

High-Efficiency Conversion: Seamlessly compatible with idle PTA units, enabling highly efficient conversion to FDCA.

Industry-Leading Quality: Delivers excellent product quality with key performance indicators leading the industry.

Globally Lowest Production Costs: Unlocking Commercial Viability

>50% Cost Reduction: Leveraging non-grain raw materials and proprietary tech to slash production costs by over 50% compared to traditional methods.

Breaking Commercialization Bottlenecks: Achieves the globally lowest production cost, effectively removing key barriers to mass commercialization.

Dual-Platform Compound Strategy: Unlocking Trillion-Dollar Application Scenarios

FDCA Platform: Extensive applications in packaging, textiles, films, lithium batteries, and engineering plastics.

GA Platform: Broad utility in daily cleaning chemicals, water treatment, healthcare, and building materials.

R&D Strength

At the heart of our innovation lies a fully integrated, independently developed R&D ecosystem. By conquering technical barriers across the entire bio-based materials value chain, we are forging a robust technological moat and leading the industry forward.

CellUranics places the highest priority on intellectual property protection. Centered around our core technological pathways, product portfolio, and manufacturing processes, we have filed dozens of core invention patents to build a comprehensive IP protection framework. This creates a self-reliant technological moat, laying a solid foundation for the company's long-term growth.

In early 2026, our independently developed method for preparing 2,5-furandicarboxylic acid (FDCA) compounds (Patent No. ZL202210234062.3) was officially granted an invention patent by the China National Intellectual Property Administration (CNIPA). This milestone establishes a dual-layer IP protection system that seamlessly integrates domestic patent authorization with international patent deployment.

Century-Long Legacy

Nearly 100 years of industrialization experience

Talent-Driven Core

An elite R&D team, with over 70% holding master’s or doctoral degrees

Innovation Powerhouse

Building self-reliant and defensible R&D barriers

Global Vision

A multi-dimensional, synergistic international strategic footprint

Pioneering Breakthroughs

Defining the industry with a proprietary technological pathway

Core Team

Leveraging deep-rooted expertise across the bio-based materials and chemical sectors, our comprehensive capabilities in R&D, industrialization, and management fuel CellUranics's continuous innovation.

Dr. Neng Guo

Founder, Chairman & CEO

Dr. Neng Guo holds a B.S. in Chemistry from the University of Science and Technology of China (2001) and a Ph.D. in Chemistry from Northwestern University (2007), where he conducted research under the supervision of Professor Tobin Marks, a member of all three U.S. National Academies. A prolific researcher, he has published over 20 papers in top-tier international academic journals.

In 2020, Dr. Guo founded CellUranics, spearheading a major technological breakthrough: the synthesis of FDCA from non-grain glucose using GA as an intermediate. This innovation has led to multiple invention patent applications. Under his strategic leadership in team building, fundraising, and industrial resource integration, CellUranics has commenced construction on its flagship 10,000-ton FDCA plant. Upon completion, it will become the world’s first large-scale facility to produce FDCA via this proprietary glucose-to-GA pathway.

Prior to founding CellUranics, Dr. Guo held key R&D positions at the U.S. Department of Energy’s Argonne National Laboratory and the global energy giant BP. He led critical projects, including cellulose-to-ethylene glycol conversion and tertiary oxidation technology for PTA, the latter of which helped BP reduce its global variable manufacturing costs by approximately US$9 million annually.